Does the Drug Shortage White Paper Fall Short?
FDA Law Blog: Biosimilars
APRIL 8, 2024
FDA previously analyzed 163 drugs that went into shortage in the 5-year period between 2013 and 2017; 63% (103) were sterile injectables and 67% (109) were drugs that have a generic version on the market. That sterile injectables may be more vulnerable to supply change disruptions is not a novel concept.
Let's personalize your content